| |
| |
|
| Insider
Information: |
Balo Andrew K |
| Relationship: |
EVP Regulatory Strateg... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
50,908 |
|
|
Indirect Shares
|
30,212 |
|
|
| Direct
Value |
$5,894,637 |
|
|
|
Indirect Value
|
$3,498,247 |
|
|
| Total
Shares |
81,120 |
|
|
| Total
Value |
$9,392,885 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 90.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Regulatory Strateg... |
2023-03-10 |
50,908 |
2023-03-10 |
30,212 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
200 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-01-10 |
4 |
AS |
$62.86 |
$201,152 |
D/D |
(3,200) |
106,345 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-01-10 |
4 |
OE |
$9.80 |
$31,360 |
D/D |
3,200 |
109,545 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-02-10 |
4 |
OE |
$9.80 |
$7,125 |
D/D |
727 |
107,072 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-02-10 |
4 |
AS |
$79.30 |
$253,760 |
D/D |
(3,200) |
103,872 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-03-08 |
4 |
A |
$0.00 |
$29 |
D/D |
28,761 |
132,663 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-03-10 |
4 |
AS |
$77.71 |
$248,672 |
D/D |
(3,200) |
129,463 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-03-10 |
4 |
D |
$77.55 |
$1,041,505 |
D/D |
(13,430) |
116,033 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-04-10 |
4 |
AS |
$78.19 |
$250,208 |
D/D |
(3,200) |
112,833 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-05-10 |
4 |
AS |
$71.93 |
$230,176 |
D/D |
(3,200) |
109,633 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2017-06-12 |
4 |
AS |
$69.06 |
$220,989 |
D/D |
(3,200) |
106,433 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-07-10 |
4 |
AS |
$71.55 |
$228,972 |
D/D |
(3,200) |
103,233 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-08-10 |
4 |
AS |
$71.18 |
$230,921 |
D/D |
(3,244) |
99,989 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-09-11 |
4 |
D |
$71.81 |
$540,827 |
D/D |
(7,531) |
89,282 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-09-11 |
4 |
AS |
$72.27 |
$234,441 |
D/D |
(3,244) |
96,813 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-11-29 |
4 |
AS |
$60.00 |
$389,400 |
D/D |
(6,490) |
82,792 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2017-12-11 |
4 |
AS |
$61.23 |
$198,691 |
D/D |
(3,245) |
79,547 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-03-08 |
4 |
A |
$0.00 |
$39 |
D/D |
38,502 |
118,086 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-03-12 |
4 |
D |
$60.73 |
$578,095 |
D/D |
(9,519) |
108,567 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-07-16 |
4 |
AS |
$99.12 |
$497,816 |
D/D |
(5,000) |
103,567 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-08-14 |
4 |
AS |
$124.16 |
$621,253 |
D/D |
(5,000) |
98,567 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-09-10 |
4 |
S |
$143.76 |
$803,160 |
D/D |
(5,587) |
93,105 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-09-14 |
4 |
AS |
$144.46 |
$725,851 |
D/D |
(5,000) |
88,105 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-10-12 |
4 |
AS |
$124.49 |
$623,934 |
D/D |
(5,000) |
83,105 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-11-14 |
4 |
AS |
$141.25 |
$715,664 |
D/D |
(5,000) |
78,105 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Reg. Strategy, Clinical |
• – – |
2018-12-14 |
4 |
AS |
$120.23 |
$606,167 |
D/D |
(5,000) |
73,105 |
0 |
- |
|
200 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
